Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Bond Market
BND
|
+$1.02B |
| 2 |
Canadian Natural Resources
CNQ
|
+$958M |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$896M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$861M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$756M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.62B |
| 2 |
Amgen
AMGN
|
+$1.68B |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.18B |
| 4 |
Visa
V
|
+$1.05B |
| 5 |
Invesco QQQ Trust
QQQ
|
+$1B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.79% |
| 2 | Healthcare | 9.32% |
| 3 | Financials | 8.97% |
| 4 | Consumer Discretionary | 7.33% |
| 5 | Industrials | 5.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1976
Kilroy Realty
KRC
$4.34B
| $19.4M | ﹤0.01% |
502,066
-360,672
| -42% | -$14.9M |
|
1977
Empire State Realty Trust
ESRT
$843M
| $19.4M | ﹤0.01% |
2,879,691
+1,223,802
| +74% | +$8.62M |
|
1978
CALL
Datadog
DDOG
$81.6B
| $19.4M | ﹤0.01% |
263,700
+96,300
| +58% | +$7.52M |
|
1979
FTI Consulting
FCN
$4.17B
| $19.4M | ﹤0.01% |
121,960
+61,763
| +103% | +$10.3M |
|
1980
Onto Innovation
ONTO
$13.4B
| $19.3M | ﹤0.01% |
283,800
-131,396
| -32% | -$9.44M |
|
1981
Grand Canyon Education
LOPE
$3.88B
| $19.3M | ﹤0.01% |
182,858
+12,265
| +7% | +$1.22M |
|
|
LSXMA
1982
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
| $19.3M | ﹤0.01% |
667,200
-155,379
| -19% | -$4.73M |
|
1983
Vanguard Communication Services ETF
VOX
$5.73B
| $19.3M | ﹤0.01% |
234,117
+61,298
| +35% | +$5.17M |
|
1984
Saic
SAIC
$5.25B
| $19.2M | ﹤0.01% |
173,495
+8,535
| +5% | +$900K |
|
1985
Liberty Energy
LBRT
$3.27B
| $19.2M | ﹤0.01% |
1,200,605
+711,606
| +146% | +$11.3M |
|
1986
Crane NXT
CXT
$3.13B
| $19.2M | ﹤0.01% |
550,511
-29,006
| -5% | -$1.01M |
|
1987
Macerich
MAC
$6.66B
| $19.2M | ﹤0.01% |
1,702,351
-471,805
| -22% | -$5.33M |
|
1988
Vaxcyte
PCVX
$8.5B
| $19.1M | ﹤0.01% |
399,364
-88,519
| -18% | -$3.47M |
|
|
MPT
1989
Medical Properties Trust
MPT
$2.75B
| $19.1M | ﹤0.01% |
1,718,418
-5,496,417
| -76% | -$63.9M |
|
1990
CareTrust REIT
CTRE
$9.72B
| $19.1M | ﹤0.01% |
1,029,485
+389,171
| +61% | +$7.26M |
|
1991
CNA Financial
CNA
$14.2B
| $19.1M | ﹤0.01% |
452,167
+86,115
| +24% | +$3.53M |
|
1992
Cactus
WHD
$5.5B
| $19.1M | ﹤0.01% |
380,252
+48,147
| +14% | +$2.41M |
|
1993
UFP Industries
UFPI
$5.19B
| $19.1M | ﹤0.01% |
240,677
-57,144
| -19% | -$4.37M |
|
1994
CALL
Broadcom
AVGO
$2T
| $19.1M | ﹤0.01% |
341,000
+248,000
| +267% | +$12.4M |
|
1995
Clear Secure
YOU
$5.34B
| $19.1M | ﹤0.01% |
695,046
-545,695
| -44% | -$15M |
|
|
GES
1996
DELISTED
Guess Inc
GES
| $19.1M | ﹤0.01% |
921,312
+263,449
| +40% | +$4.85M |
|
|
CMBT
1997
CMB.TECH NV
CMBT
$4.76B
| $19.1M | ﹤0.01% |
1,118,509
-276,063
| -20% | -$4.98M |
|
|
MIR.WS
1998
DELISTED
Mirion Technologies, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
MIR.WS
| $19M | ﹤0.01% |
17,000,000
| – | – |
|
1999
John B. Sanfilippo & Son
JBSS
$976M
| $19M | ﹤0.01% |
234,075
+54,369
| +30% | +$4.43M |
|
2000
Relay Therapeutics
RLAY
$4.3B
| $19M | ﹤0.01% |
1,273,415
-152,888
| -11% | -$2.93M |
|
Similar funds
Goldman Sachs's Q4 2022 Portfolio in Review
As of Q4 2022, Goldman Sachs held 6,669 positions worth $408B, up 3.1% from $396B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Goldman Sachs withdrew a net $13.2B in Q4 2022, closing 721 positions and reducing 2,588 holdings. Its most notable exit was ChemoCentryx, Inc., an estimated $290M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Goldman Sachs opened a new position in Perfect Corp worth $104M.
- Goldman Sachs's largest Q4 2022 buy was Perfect Corp: 14,518,235 shares worth $104M.
- Goldman Sachs added most to Vanguard Total Bond Market in Q4 2022, an estimated $1.02B increase.
- Goldman Sachs's biggest Q4 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.62B.
- Goldman Sachs fully exited ChemoCentryx, Inc. in Q4 2022, selling an estimated $290M.
- Goldman Sachs's ten largest holdings make up 15% of its $408B portfolio in Q4 2022.
- Goldman Sachs opened 429 new positions and closed 721 in Q4 2022.
- Goldman Sachs's portfolio value rose 3.1% quarter-over-quarter to $408B.
Based on Goldman Sachs's 13F filing for Q4 2022, filed 13 Feb 2023.